Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis

Scandinavian Journal of Urology and Nephrology

Volumn 41, Issue 3, 2007, Pages 237-242

  Lizakowski, Slawomir ^a   Zdrojewski, Zbigniew ^a   Jagodziński, Piotr ^a   Rutkowski, Boleslaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Coagulation; Glomerulonephritis; Nephrotic syndrome; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

BIOLOGICAL MARKER; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLOMERULONEPHRITIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; ANTITHROMBIN III; BLOOD COAGULATION; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROTEIN PRECURSORS; PROTEINURIA; PROTHROMBIN; THROMBOPLASTIN;

EID: 34247590926     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590601016511     Document Type: Article

References (30)

1. Nemerson Y. Tissue factor and hemostasis. Blood 1988;71: 1-8.
2. Werling RW, Zacharski LR, Kisiel W, Bajaj SP, Memoli VA, Rousseau SM. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost 1993;69:366-9.
3. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action Blood 1988;71:335-43.
4. Green J, Doughty L, Kaplan SS, Sasser H, Carcillo JA. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure. Thromb Haemost 2002;87:218-23.
5. Levi M. Disseminated intravascular coagulation: what's new? Crit Care Clin 2005;21:449-67.
6. Smithies MN, Weaver CB. Role of the tissue factor pathway in the pathogenesis and management of multiple organ failure. Blood Coagul Fibrinolysis 2004;15(Suppl 1):S11-20.
7. Kakkar AK, DeRuvo N, Chinswangwatanakul V, Tebbutt S, Williamson RC. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995;346:1004-5.
8. Versteeg HH, Spek CA, Peppelenbosch MP, Richel DJ. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med 2004;10:6-11.
9. Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 1998;79:495-9.
10. Marutsuka K, Hatakeyama K, Yamashita A, Asada Y. Role of thrombogenic factors in the development of atherosclerosis. J Atheroscler Thromb 2005;12:1-8.
11. Erlich JH, Apostolopoulos J, Wun TC, Kretzmer KK, Holdsworth SR, Tipping PG. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 1996;98:325-35.
12. Hancock W, Atkins R. Activation of coagulation pathways and fibrin deposition in human glomerulonephritis. Semin Nephrol 1985;5:69-77.
13. Cunningham MA, Kitching AR, Tipping PG, Holdsworth SR. Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis. Kidney Int 2004;66:647-54.
14. Neale TJ, Tipping PG, Carson SD, Holdsworth SR. Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet 1988;2:421-4.
15. Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int 1994;46: 287-96.
16. Zdrojewski Z, Lizakowski S, Raszeja-Specht A, Skibowska A, Rutkowski B. Influence of spontaneous platelet aggregation on progression of glomerular disease. Nephron 2002;92: 36-42.
17. Erlich JH, Holdsworth SR, Tipping PG. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol 1997;150:873-80.
18. Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost 1997;78:759-64.
19. Lwaleed BA, Bass PS, Chisholm M, Francis JL. Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury? J Clin Pathol 1997;50:336-40.
20. Osterud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995;73:873-5.
21. Tipping PG, Erlich JH, Apostolopoulos J, Mackman N, Loskutoff D, Holdsworth SR. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA. Am J Pathol 1995; 147:1736-48.
22. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis. Am J Kidney Dis 2000;35:726-38.
23. Ott I, Andrassy M, Zieglgansberger D, Geith S, Schomig A, Neumann FJ. Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood 2001;97:3721-6.
24. Malyszko J, Malyszko JS, Mysliwiec M. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Blood Coagul Fibrinolysis 2002;13:615-21.
25. Joles JA, Stroes ES, Rabelink TJ. Endothelial function in proteinuric renal disease. Kidney Int Suppl 1999;71:S57-61.
26. Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets. Platelets 2002;13:247-53.
27. Kokawa T, Abumiya T, Kimura T, Harada-Shiba M, Koh H, Tsushima M, et al. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia. Arterioscler Thromb Vasc Biol 1995;15:504-10.
28. Kawaguchi A, Miyao Y, Noguchi T, Nonogi H, Yamagishi M, Miyatake K, et al. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II. Arterioscler Thromb Vasc Biol 2000;20:251-8.
29. Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli E. Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 1997;17:265-72.
30. Lwaleed BA, Bass PS. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol 2006;208:327-39.